Analysts’ Viewpoint on Radiation Therapy Market Scenario
Cancer patients are at a high risk of contracting COVID-19; therefore, health care facilities and cancer centers are increasing awareness about the vaccination of patients. Companies in the global radiation therapy market have witnessed strong growth due to advancements in technology. For instance, Elekta received the CE mark approval for Elekta Unity magnetic resonance radiation system for commercial sale in Europe. Product advancements, such as new digital solutions, are driving the demand for radiation therapy. Various trends in radiation therapy, such as flash therapy, image-guided therapy, synthetic CT from MRI, and artificial intelligence used in radiotherapy, are also augmenting the global market. For instance, Accuray Incorporated received approval from the Atomic Energy Regulatory Board for its Radixact X9 System in India.
Radiotherapy, also called radiation therapy, is a treatment provided to cancer patients. In this therapy, tumor cells are killed by using X-rays. External beam therapy and internal radiation therapy are the two primary types of radiotherapy. Radiotherapy depends on various factors such as type of cancer, size of the tumor, location of the tumor in the body, and other general parameters of the body.
Flash therapy is one of the key trends in radiation oncology. Furthermore, image-guided radiotherapy has become popular in the market. Emerging economies such as India, China, Brazil, and Malaysia offer numerous opportunities in the health care sector. Development of health care systems in these countries is propelling the demand for radiation therapy for cancer and radiation therapy equipment.
Technological advancements have been driving the global radiation therapy market over the last few years. Increase in R&D activities, rise in number of patients suffering from diseases such as cancer, and rapid growth of the health care sector in developed and developing economies have led to the introduction of new & technologically superior systems for treatment. This is likely to propel the global radiation therapy market in the next few years.
There has been a paradigm shift in the health care sector in terms of usage of methods to treat diseases, from those causing substantial pain to those that are minimally invasive and cause less pain.
Brachytherapy is one such painless therapy compared to X-ray therapy. Brachytherapy kills tumor cells or cancer cells without causing any harm or pain to the cancer patient. Treatments are delivered with a series of daily sessions or over a prescribed period. Rise in preference for non-invasive treatment procedures is creating lucrative opportunities for players in the global radiation therapy market.
The number of cancer patients is increasing rapidly across the globe. According to the WHO, cancer was the second largest cause of death globally, accounting for 10 million deaths in 2020. Cancer accounts for an estimated 9.6 million deaths (one in six deaths) globally each year. According to the American Institute of Cancer Research, around 18 million cancer cases were diagnosed across the world in 2018. Thus, increase in number of cancer patients is driving the global radiation therapy market.
In terms of type, the global radiation therapy market has been bifurcated into external beam radiation therapy and internal radiation therapy. The external beam radiation therapy segment accounted for a large share of the global market in 2021. Increase in incidence and prevalence rates of cancer in developing and developed countries across the world, rise in technological advancements, and surge in health care spending are projected to boost the global radiation therapy market during the forecast period.
Cancer centers are making external beam radiation therapies, such as 3-D conformal radiation therapy, intensity-modulated radiation therapy (IMRT), and stereotactic radiosurgery, increasingly available to improve patient outcomes. Such therapy options are enabling health care companies to increase their R&D activities in oncology radiation therapy.
Based on end-user, the global radiation therapy has been divided into hospitals, specialty clinics, and others. The hospitals segment is projected to account for major share of the global market during the forecast period. This can be attributed to the rise in cancer patient population and growth in usage of various radiation therapies in hospitals. Surgeons are increasingly adopting intraoperative radiation therapy (IORT) in hospitals, since IORT facilitates higher effective doses of radiation as compared to the conventional radiation therapy.
North America is projected to account for substantial share of the global radiation therapy market from 2022 to 2031. Increase in incidence of cancer, new product approvals, rise in mergers & acquisitions, and surge in health care expenditure are anticipated to augment the radiation therapy market in the region during the forecast period. According to the CDC, the total number of new cases of cancer in the U.S. is likely to increase by 24% in men and nearly 21% in women every year.
Rise in research & development activities, availability of more efficient & precise treatments for cancer, and collaborations among manufacturers are anticipated to drive the market in Europe during the forecast period. The market in Germany is expected to advance at a high CAGR from 2022 to 2031. This is evident as health care providers are paying more attention to radiotherapy patient positioning, as this technique helps give a patient more radiation in fewer sessions, thus saving upon time and money.
Rise in number of local players and presence of rapidly developing countries such as India are likely to augment the market in Asia Pacific. Increase in launch of new products by manufacturers is also projected to drive the radiation therapy market in Asia Pacific in the next few years.
The global radiation therapy market is consolidated, with a small number of large players accounting for a significant share. Leading companies are making significant investments in research & development activities. Diversification of product portfolios and mergers & acquisitions are the important strategies adopted by key players. Elekta AB, Varian Medical Systems, IBA Radiopharma Solutions, Accuray Incorporated, Isoray, Inc., Mevion Medical Systems, Hitachi, Ltd., ViewRay, Inc., and Panacea Medical Technologies Pvt. Ltd. are the prominent players operating in the global radiation therapy market.
Each of these players has been profiled in the radiation therapy market report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 6.3 Bn |
|
Market Forecast Value in 2031 |
US$ 10.6 Bn |
|
Growth Rate (CAGR) |
5.4% |
|
Forecast Period |
2022–2031 |
|
Historical Data Available for |
2017–2020 |
|
Quantitative Units |
US$ Mn for Value & Tons for Volume |
|
Market Analysis |
It includes cross segment analysis at global as well as regional level. Furthermore, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
The global radiation therapy market was valued at US$ 6.3 Bn in 2021
The global radiation therapy market is projected to reach more than US$ 10 Bn by 2031
The global radiation therapy market grew at a CAGR of 3.9% from 2017 to 2021
The global radiation therapy market is anticipated to expand at a CAGR of 5.4% from 2022 to 2031
Increase in incidence of cancer and rise in demand for non-invasive treatment procedures drive the global radiation therapy market
North America is projected to account for major share of the global market during the forecast period
Prominent players in the global radiation therapy market include Elekta AB, Varian Medical Systems, IBA Radiopharma Solutions, Accuray Incorporated, Isoray, Inc., Mevion Medical Systems, Hitachi, Ltd., ViewRay, Inc., and Panacea Medical Technologies Pvt. Ltd.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Radiation Therapy Market
4. Market Overview
4.1. Introduction
4.1.1. Therapy Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Radiation Therapy Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Healthcare Industry Overview
6. Global Radiation Therapy Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017-2031
6.3.1. External Beam Radiation Therapy
6.3.1.1. Conformal Radiation Therapy
6.3.1.2. Proton Beam Therapy
6.3.1.3. Image-guided Radiation Therapy
6.3.1.4. Stereotactic Radiation Therapy
6.3.1.5. Others
6.3.2. Internal Radiation Therapy
6.3.2.1. Brachytherapy
6.3.2.2. Systemic Radiation Therapy
6.4. Market Attractiveness Analysis, by Type
7. Global Radiation Therapy Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017-2031
7.3.1. Hospitals
7.3.2. Specialty Clinics
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Radiation Therapy Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Radiation Therapy Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Type, 2017-2031
9.2.1. External Beam Radiation Therapy
9.2.1.1. Conformal Radiation Therapy
9.2.1.2. Proton Beam Therapy
9.2.1.3. Image-guided Radiation Therapy
9.2.1.4. Stereotactic Radiation Therapy
9.2.1.5. Others
9.2.2. Internal Radiation Therapy
9.2.2.1. Brachytherapy
9.2.2.2. Systemic Radiation Therapy
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017-2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Radiation Therapy Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017-2031
10.2.1. External Beam Radiation Therapy
10.2.1.1. Conformal Radiation Therapy
10.2.1.2. Proton Beam Therapy
10.2.1.3. Image-guided Radiation Therapy
10.2.1.4. Stereotactic Radiation Therapy
10.2.1.5. Others
10.2.2. Internal Radiation Therapy
10.2.2.1. Brachytherapy
10.2.2.2. Systemic Radiation Therapy
10.3. Market Value Forecast, by End-user, 2017-2031
10.3.1. Hospitals
10.3.2. Specialty Clinics
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017-2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Radiation Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017-2031
11.2.1. External Beam Radiation Therapy
11.2.1.1. Conformal Radiation Therapy
11.2.1.2. Proton Beam Therapy
11.2.1.3. Image-guided Radiation Therapy
11.2.1.4. Stereotactic Radiation Therapy
11.2.1.5. Others
11.2.2. Internal Radiation Therapy
11.2.2.1. Brachytherapy
11.2.2.2. Systemic Radiation Therapy
11.3. Market Value Forecast, by End-user, 2017-2031
11.3.1. Hospitals
11.3.2. Specialty Clinics
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017-2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Radiation Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017-2031
12.2.1. External Beam Radiation Therapy
12.2.1.1. Conformal Radiation Therapy
12.2.1.2. Proton Beam Therapy
12.2.1.3. Image-guided Radiation Therapy
12.2.1.4. Stereotactic Radiation Therapy
12.2.1.5. Others
12.2.2. Internal Radiation Therapy
12.2.2.1. Brachytherapy
12.2.2.2. Systemic Radiation Therapy
12.3. Market Value Forecast, by End-user, 2017-2031
12.3.1. Hospitals
12.3.2. Specialty Clinics
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017-2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Radiation Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017-2031
13.2.1. External Beam Radiation Therapy
13.2.1.1. Conformal Radiation Therapy
13.2.1.2. Proton Beam Therapy
13.2.1.3. Image-guided Radiation Therapy
13.2.1.4. Stereotactic Radiation Therapy
13.2.1.5. Others
13.2.2. Internal Radiation Therapy
13.2.2.1. Brachytherapy
13.2.2.2. Systemic Radiation Therapy
13.3. Market Value Forecast, by End-user, 2017-2031
13.3.1. Hospitals
13.3.2. Specialty Clinics
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017-2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player - Competition Matrix (by tier and size of companies)
14.2. Market Share Analysis, by Company, 2021
14.3. Company Profiles
14.3.1. Elekta AB
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Financial Overview
14.3.1.3. Product Portfolio
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Varian Medical Systems
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Financial Overview
14.3.2.3. Product Portfolio
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. IBA Radiopharma Solutions
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Financial Overview
14.3.3.3. Product Portfolio
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Accuray Incorporated
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Financial Overview
14.3.4.3. Product Portfolio
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. Isoray, Inc.
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Financial Overview
14.3.5.3. Product Portfolio
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Mevion Medical Systems
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Financial Overview
14.3.6.3. Product Portfolio
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Hitachi, Ltd.
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Financial Overview
14.3.7.3. Product Portfolio
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. ViewRay, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Financial Overview
14.3.8.3. Product Portfolio
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. Panacea Medical Technologies Pvt. Ltd.
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Financial Overview
14.3.9.3. Product Portfolio
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
List of Tables
Table 01: Global Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 02: Global Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 03: Global Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 04: Global Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 05: Global Radiation Therapy Market Size (US$ Mn) Forecast, by Region, 2017-2031
Table 06: North America Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country, 2016–2018
Table 07: North America Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 08: North America Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 09: North America Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 10: North America Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 11: Europe Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 12: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 13: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 14: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 15: Europe Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 16: Asia Pacific Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 17: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 18: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 19: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 20: Asia Pacific Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 21: Latin America Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 22: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 23: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 24: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 25: Latin America Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031
Table 26: Middle East & Africa Radiation Therapy Market Size Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
Table 27: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by Type, 2017-2031
Table 28: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by External Beam Radiation Therapy, 2017-2031
Table 29: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by Internal Radiation Therapy, 2017-2031
Table 30: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, by End-user, 2017-2031
List of Figures
Figure 01: Global Radiation Therapy Market Size Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Radiation Therapy Market Value Share (%), by Type, 2017
Figure 03: Global Radiation Therapy Market Value Share (%), by End user, 2017
Figure 04: Global Radiation Therapy Market Value Share (%), by Region, 2017
Figure 05: Global Radiation Therapy Market Value Share (%), by External Beam Radiation Therapy, 2017
Figure 06: Global Radiation Therapy Market Value Share (%), by Internal Radiation Therapy, 2017
Figure 07: Global Radiation Therapy Market Value Share (%), by Type, 2018 and 2026
Figure 08: Global Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026
Figure 09: Global Radiation Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by External Beam Radiation Therapy, 2017-2031
Figure 10: Global Radiation Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Internal Radiation Therapy, 2017-2031
Figure 11: Global Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026
Figure 12: Global Radiation Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017-2031
Figure 13: Global Radiation Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017-2031
Figure 14: Global Radiation Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017-2031
Figure 15: Global Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026
Figure 16: Global Radiation Therapy Market Value Share Analysis, by Region, 2018 and 2026
Figure 17: Global Radiation Therapy Market Attractiveness Analysis, by Region, 2018–2026
Figure 18: North America Radiation Therapy Market Size (US$ Mn) Forecast, 2017-2031
Figure 19: North America Radiation Therapy Market Value Share Analysis, by Country, 2018 and 2026
Figure 20: North America Radiation Therapy Market Attractiveness Analysis, by Country, 2018–2026
Figure 21: North America Radiation Therapy Market Value Share (%), by Type, 2018 and 2026
Figure 22: North America Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026
Figure 23: North America Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026
Figure 24: North America Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026
Figure 25: Europe Radiation Therapy Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
Figure 26: Europe Radiation Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
Figure 27: Europe Radiation Therapy Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 28: Europe Radiation Therapy Market Value Share (%), by Type, 2018 and 2026
Figure 29: Europe Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026
Figure 30: Europe Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026
Figure 31: Europe Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026
Figure 32: Asia Pacific Radiation Therapy Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
Figure 33: Asia Pacific Radiation Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
Figure 34: Asia Pacific Radiation Therapy Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 35: Asia Pacific Radiation Therapy Market Value Share (%), by Type, 2018 and 2026
Figure 36: Asia Pacific Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026
Figure 37: Asia Pacific Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026
Figure 38: Asia Pacific Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026
Figure 39: Latin America Radiation Therapy Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2031
Figure 40: Latin America Radiation Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
Figure 41: Latin America Radiation Therapy Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 42: Latin America Radiation Therapy Market Value Share (%), by Type, 2018 and 2026
Figure 43: Latin America Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026
Figure 44: Latin America Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026
Figure 45: Latin America Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026
Figure 46: Middle East & Africa Radiation Therapy Market Size (US$ Mn) Forecast, 2017-2031
Figure 47: Middle East & Africa Radiation Therapy Market Value Share Analysis, by Country/Sub-region, 2018 and 2026
Figure 48: Middle East & Africa Radiation Therapy Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 49: Middle East & Africa Radiation Therapy Market Value Share (%), by Type, 2018 and 2026
Figure 50: Middle East & Africa Radiation Therapy Market Attractiveness Analysis, by Type, 2018–2026
Figure 51: Middle East & Africa Radiation Therapy Market Value Share Analysis, by End-user, 2018–2026
Figure 52: Middle East & Africa Radiation Therapy Market Attractiveness Analysis, by End-user, 2018–2026
Figure 53: Global Radiation Therapy Market Share, by Company, 2017
Figure 54: Elekta AB Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2018
Figure 55: Elekta AB Breakdown of Net Sales, by Region/Sub-Region, 2017/2018
Figure 56: Elekta AB Breakdown of Research & Development Expenses (US$ Mn), 2016–2018
Figure 57: Varian Medical Systems Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 58: Varian Medical Systems Breakdown of Net Sales, by Region, 2017
Figure 59: Varian Medical Systems Breakdown of Net Sales, by Business Segment, 2017/2018
Figure 60: Varian Medical Systems Research & Development Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018
Figure 61: IBA Radiopharma Solutions Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 62: IBA Radiopharma Solutions Breakdown of Net Sales, by Therapy, 2018
Figure 63: IBA Radiopharma Solutions R & D Investments (US$ Mn) & Y-o-Y Growth (%), 2016–2018
Figure 64: Accuray Incorporated Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 65: Accuray Incorporated Breakdown of Net Sales, by Region, 2018
Figure 66: Accuray Incorporated R&D Investments (US$ Mn) & Y-o-Y Growth (%), 2016–2018
Figure 67: Accuray Incorporated Breakdown of Net Sales, by Business Segment, 2018
Figure 68: Isoray, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018
Figure 69: Isoray, Inc. Breakdown of Net Sales, by Region, 2018
Figure 70: Isoray, Inc. R&D investments (US$ Mn) and Y-o-Y Growth (%), 2017–2018
Figure 71: Isoray, Inc. Breakdown of Net Sales, by Business Segment, 2018
Figure 72: Hitachi, Ltd. Revenue (US$ Bn) and Y-o-Y Growth (%), 2015–2018
Figure 73: Hitachi, Ltd. Healthcare Business Segment Breakdown of Net Sales (%), by Region, 2018
Figure 74: Hitachi, Ltd. Healthcare Business Segment Breakdown of Net Sales (%), by Sub-segment, 2018
Figure 75: ViewRay, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2016–2018
Figure 76: ViewRay, Inc. Breakdown of Net Sales, by Region, 2018
Figure 77: ViewRay, Inc. R & D Investments (US$ Mn) & Y-o-Y Growth (%), 2016–2018
Figure 78: ViewRay, Inc. Breakdown of Net Sales, by Business Segment, 2018
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Radiation Therapy Market
